1,512
Views
22
CrossRef citations to date
0
Altmetric
Review Article

Regulation of stressed-induced cell death by the Bcl-2 family of apoptotic proteins

Pages 89-99 | Received 15 Mar 2017, Accepted 31 Oct 2017, Published online: 23 Nov 2017

References

  • Adams JM, Cory S. 2007. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26:1324–1337.
  • Alves NL, Derks IA, Berk E, Spijker R, van Lier RA, Eldering E. 2006. The Noxa/Mcl-1 axis regulates susceptibility to apoptosis under glucose limitation in dividing T cells. Immunity 24:703–716.
  • Antignani A, Youle RJ. 2006. How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane? Curr Opin Cell Biol 18:685–689.
  • Ashkenazi A, Fairbrother WJ, Leverson JD, Souers AJ. 2017. From basicapoptosis discoveries to advanced selective BCL-2 family inhibitors. Nat Rev Drug Discov 16:273–284.
  • Baou M, Kohlhaas SL, Butterworth M, Vogler M, Dinsdale D, Walewska R, et al. 2010. Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cells. Haematologica 95:1510–1518.
  • Borner C. 2003. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol 39:615–647.
  • Charvet C, Wissler M, Brauns-Schubert P, Wang S-J, Tang Y, Sigloch FC, Mellert H. 2011. Phosphorylation of Tip60 by GSK-3 determines the induction of PUMA and apoptosis by p53. Mol Cell 42:584–596.
  • Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, et al. 2005. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17:393–403.
  • Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ, Green DR. 2010. The BCL-2 family reunion. Mol Cell 37:299–310.
  • Cory S, Adams JM. 2002. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2:647–656.
  • Cory S, Huang DC, Adams JM. 2003. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22:8590–8607.
  • Czabotar PE, Lessene G, Strasser A, Adams JM. 2014. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 15:49–63.
  • Du C, Fang M, Li Y, Li L, Wang X. 2000. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102:33–42.
  • Edinger AL, Thompson CB. 2004. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 16:663–669.
  • Er E, Oliver L, Cartron PF, Juin P, Manon S, Vallette FM. 2006. Mitochondria as the target of the pro-apoptotic protein Bax. Biochim Biophys Acta 1757:1301–1311.
  • Fadeel B, Orrenius S, Zhivotovsky B. 1999. Apoptosis in human disease: a new skin for the old ceremony? Biochem Biophys Res Commun 266:699–717.
  • Fei P, Bernhard EJ, El-Deiry WS. 2002. Tissue-specific induction of p53 targets in vivo. Cancer Res 62:7316–7327.
  • Fernandez Y, Verhaegen M, Miller TP, Rush JL, Steiner P, Opipari AW Jr, et al. 2005. Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. Cancer Res 65:6294–6304.
  • Fischer SF, Belz GT, Strasser A. 2008. BH3-only protein PUMA contributes to death of antigen-specific T cells during shutdown of an immune response to acute viral infection. Proc Natl Acad Sci USA 105:3035–3040.
  • Flinterman M, Guelen L, Ezzati-Nik S, Killick R, Melino G, Tominaga K, et al. 2005. E1A activates transcription of p73 and Noxa to induce apoptosis. J Biol Chem 280:5945–5959.
  • Fricker M, O’Prey J, Tolkovsky AM, Ryan KM. 2010. Phosphorylation of PUMA modulates its apoptotic function by regulating protein stability. Cell Death Dis 1:e59.
  • Green DR, Evan GI. 2002. A matter of life and death. Cancer Cell 1:19–30.
  • Han J-w, Flemington C, Houghton AB, Gu Z, Zambetti GP, Lutz RJ, et al. 2001. Expression of bbc3, a proapoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc Natl Acad Sci USA 98:11218–11323.
  • Happo L, Strasser A, Cory S. 2012. BH3-only proteins in apoptosis at a glance. J Cell Sci 125:1081–1987.
  • Hardwick JM, Soane L. 2013. Multiple functions of BCL-2 family proteins. ColdSpring Harb Perspect Biol Cold Spring Harbor Lab 5:a008722.
  • Hengartner MO. 2000. The biochemistry of apoptosis. Nature 407:770–776.
  • Hershko T, Ginsberg D. 2004. Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. J Biol Chem 279:8627–8634.
  • Hijikata M, Kato N, Sato T, Kagami Y, Shimotohno K. 1990. Molecular cloning and characterization of a cDNA for a novel phorbol-12-myristate-13-acetate-responsive gene that is highly expressed in an adult T-cell leukemia cell line. J Virol 64:4632–4639.
  • Hikisz P, Kiliańska ZM, 2012. PUMA, a critical mediator of cell death-one decade on from its discovery. Cell Mol Biol Lett 17:646–669.
  • Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. 2009. Cell death. New Engl J Med 361:1570–1583.
  • Jeffers JR, Parganas E, Lee Y, Yang C, Wang JLing, Brennan J, et al. 2003. PUMA is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4:321–328.
  • Kamada S, Shimono A, Shinto Y, Tsujimura T, Takahashi T, Noda T, et al. 1995. bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine. Cancer Res 55:354–359.
  • Kerr JF. 1965. A histochemical study of hypertrophy and ischaemic injury of rat liver with special reference to changes in lysosomes. J Pathol Bacteriol 90:419–435.
  • Kerr JF, Wyllie AH, Currie AR. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–257.
  • Kihlmark M, Imreh G, Hallberg E. 2001. Sequential degradation of proteins from the nuclear envelope during apoptosis. J Cell Sci 114:3643–3653.
  • Kim JY, Ahn HJ, Ryu JH, Suk K, Park JH. 2004. BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J Exp Med 199:113–124.
  • Kim H, Rafiuddin-Shah M, Tu HC, Jeffers JR, Zambetti GP, Hsieh JJ, Cheng EH. 2006. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 8:1348–1358.
  • Krammer PH. 2000. CD95’s deadly mission in the immune system. Nature 407:789–795.
  • Kuwana T, Bouchier-Hayes L, Chipuk JE, Bonzon C, Sullivan BA, Green DR, Newmeyer DD. 2005. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 17:525–535.
  • Leverson JD, Phillips DC, Mitten MJ, Boghaert ER, Diaz D, Tahir SK, et al. 2015. Exploitingselective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy. Sci Transl Med 7:279ra40.
  • Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479–489.
  • Li H, Zhu H, Xu CJ, Yuan J. 1998. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491–501.
  • Liadis N, Murakami K, Eweida M, Elford AR, Sheu L, Gaisano HY, et al. 2005. Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus. Mol Cell Biol 25:3620–3629.
  • Lomonosova E, Chinnadurai G. 2008. BH3-only proteins in apoptosis and beyond: an overview. Oncogene 27(Suppl. 1):S2–S19.
  • Lowman XH, McDonnell MA, Kosloske A, Odumade OA, Jenness C, Karim CB, et al. 2010. The proapoptotic function of Noxa in human leukemia cells is regulated by the kinase Cdk5 and by glucose. Mol Cell 40:823–833.
  • Mattson MP. 2000. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1:120–129.
  • Meier P, Finch A, Evan G. 2000. Apoptosis in development. Nature 407:796–801.
  • Meier P, Vousden KH. 2007. Lucifer’s labyrinth-ten years of path finding in cell death. Mol Cell 28:746–754.
  • Michalak EM, Villunger A, Adams JM, Strasser A. 2008. In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute. Cell Death Differ 15:1019–1029.
  • Mosser DD, Morimoto RI. 2004. Molecular chaperones and the stress of oncogenesis. Oncogene 23:2907–2918.
  • Muller PAJ, Vousden KH. 2013. p53 mutations in cancer. Nat Cell Biol 15:2–8.
  • Nakano K, Vousden KH. 2001. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7:683–694.
  • Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, et al. 2000. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288:1053–1058.
  • Perciavalle RM, Opferman JT. 2013. Delving deeper: MCL-1’s contributions to normal and cancer biology. Trends Cell Biol 2013 23:22–29.
  • Peter ME, Krammer PH. 2003. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 10:26–35.
  • Ploner C, Kofler R, Villunger A. 2008. Noxa: at the tip of the balance between life and death. Oncogene 27(Suppl. 1):S84–S92.
  • Qin JZ, Ziffra J, Stennett L, Bodner B, Bonish BK, Chaturvedi V, et al. 2005. Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells. Cancer Res 65:6282–6293.
  • Rathmell JC, Thompson CB. 2002. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 109:S97–S107.
  • Riedl SJ, Shi Y. 2004. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5:897–907.
  • Rohn TT, Head E. 2009. Caspases as therapeutic targets in Alzheimer’s disease: is it time to “cut” to the chase? Int J Clin Exp Pathol 2:108–118.
  • Roufayel R, Kadry S. 2017. Expression of miR-23a by apoptotic regulators in human cancer: a review. Cancer Biol Ther 0:1–8.
  • Seo YW, Shin JN, Ko KH, Cha JH, Park JY, Lee BR, et al. 2003. The molecular mechanism of Noxa-induced mitochondrial dysfunction in p53-mediated cell death. J Biol Chem 278:48292–48299.
  • Shan Z, Liu Q, Li Y, Wu J, Sun D, Gao Z. 2017. PUMA decreases the growth of prostate cancer PC-3 cells independent of p53. Oncol Lett 13:1885–1890.
  • Strasser A, Cory S, Adams JM. 2011. Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J 30:3667–3683.
  • Taylor RC, Cullen SP, Martin SJ. 2008. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9:231–241.
  • Thompson CB. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456–1462.
  • Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. 1984. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226:1097–1099.
  • Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, et al. 2008. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 27:433–446.
  • Vaux DL, Cory S, Adams JM. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440–442.
  • Vaux DL, Strasser A. 1996. The molecular biology of apoptosis. Proc Natl Acad Sci USA 93:2239–2244.
  • Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ. 1993. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229–240.
  • Wang Z, Sun Y. 2008. Identification and characterization of two splicing variants of human Noxa. Anticancer Res 28:1667–1674.
  • Wei J, O’Brien D, Vilgelm A, Piazuelo MB, Correa P, Washington MK, et al. 2008. Interaction of Helicobacter pylori with gastric epithelial cells is mediated by the p53 protein family. Gastroenterology 134:1412–1423.
  • Wolf BB, Green DR. 1999. Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem 274:20049–20052.
  • Wu B, Qiu W, Wang P, Yu H, Cheng T, Zambetti GP, et al. 2007. p53 independent induction of PUMA mediates intestinal apoptosis in response to ischaemia-reperfusion. Gut 56:645–654.
  • Yang H, Xie Y, Yang D, Ren D. 2017. Oxidative stress-induced apoptosis in granulosa cells involves JNK, p53 and Puma. Oncotarget 8:25310–25322.
  • Yoo H, Cha HJ, Lee J, Yu EO, Bae S, Jung JH, et al. 2008. Specific proteolysis of the A-kinase-anchoring protein 149 at the Asp582 residue by caspases during apoptosis. Oncol Rep 19:1577–1582.
  • Youle RJ, Strasser A. 2008. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9:47–59.
  • Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L. 2003. PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci USA 100:1931–1936.
  • Yu J, Zhang L. 2008. PUMA, a potent killer with or without p53. Oncogene 27:71–83.
  • Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B. 2001. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell Biol 7:673–682.
  • Zou H, Li Y, Liu X, Wang X. 1999. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 274:11549–11556.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.